Genworth 4Q24 Earning Summary Presentation

Create shareholder value through Enact's growing market value and capital returns

• Since Enact's IPO, Genworth has received over $900M in capital returns
• Executed $51M in share repurchases during the quarter
• $565M executed program-to-date through February 14, 2025, at an average price of $5.69 per share
• Repurchased $31M in principal of holding company debt at a discount during the quarter

Maintain self-sustaining, customer-centric legacy insurance companies, including the LTC, life and annuity businesses

• Continued progress on LTC1 MYRAP2 with $2.1B estimated net present value (NPV) of approvals and legal settlements in 2024
• • $40M of gross incremental premium approvals in the quarter
• Approximately $31.2B estimated NPV achieved from IFAs3 since 2012
• U.S. life insurance companies' RBC4 ratio of 306%5

Drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions

• CareScout Quality Network (CQN) now available in 50 states
• • 86% coverage6 and 493 providers
• Developing long-term care insurance products to meet growing demand
• • Inaugural CareScout Insurance LTC product, Care Assurance, filed with the Compact and in nine additional jurisdictions

4Q24 CareScout Update

Strong continued progress for CareScout Services in 2024 hitting several key objectives

CareScout Quality Network Build-Out

Percentage of Aged 65+ U.S. Census Coverage, Number

of Network Providers and Number of Active States

• CQN nationwide with ~500 providers and 86% coverage (vs 65% goal)
• 90% of providers agreeing to discounted negotiated rates below the median cost of care1
• Significant ramp in policyholders choosing CQN providers; strong growth in the fourth quarter

Looking ahead to 2025

• Expanding the CQN to include assisted living communities
• Extending the CQN and assessments to other long-term care insurers
• Scaling CareScout Services' tech enabled platform, along with investments in marketing and brand awareness

CareScout Insurance: Developing long-term care insurance products to meet growing demand

20%

0%

Active # of States

• Plan to enter the market in 2025

5

•1 Genworth Cost of Care Survey results as of 2023

$1.0 - $1.5B of Genworth claims savings expected from the CQN, as as well as revenue growth as CareScout matches care seekers and providers

Enact Segment

Primary IIF1 ($B)

Portfolio up 2% year-over-year driven by new insurance written (NIW) and continued elevated persistency

Earned Premiums ($M)

Earned premiums were lower versus prior quarter driven by higher ceded premiums and higher versus prior year as IIF growth was partially offset by higher ceded premiums

Primary NIW was up 27% versus the prior year primarily driven by higher estimated originations

Enact Segment

Benefits & Changes in

Policy Reserves ($M)

(Benefit) / Loss

Pre-tax reserve release of $56M primarily from favorable cure performance and loss mitigation activities; prior quarter and prior year included pre-tax reserve releases of $65M and $53M, respectively

Primary delinquency rate of 2.4% in line with pre-pandemic levels

New delinquencies increased from the prior year primarily from continued seasoning of large, newer books; sequential increase was primarily from hurricane-related new delinquencies, which historical experience indicates cure at a higher rate

Continued strong cure performance

Sufficiency to PMIERs2 ($M)

Enact paid a quarterly dividend of $0.185 per share in the current quarter and executed $74M in share repurchases, which resulted in total capital returns of $84M to Genworth

Estimated PMIERs sufficiency ratio was 167%, $2,052M above requirements

Focused on cash flows, economic value, and statutory earnings

• GAAP results do not impact cash flows or economic value

Strong track record demonstrated over 12+ years

• Actuarial justified premium increases
• Reduction in rich policyholder benefits (lifetime policies, inflation riders)

Continuing to work with state insurance regulators

• Solutions to strengthen Genworth's claims-paying ability and support customers with a wide range of benefit reduction options

U.S. life insurance companies managed on a standalone basis

• No plan to contribute capital from Genworth holding company
• No plan to retucapital

Approximately $31.2B2 in estimated

net present value achieved since 2012

58.3% benefit reduction rate3on a cumulative

basis

3 favorable legal settlements covering ~70%

of the block now materially complete; accelerated benefit reductions & reduced tail-risk

Additional risk mitigation factors to build resiliency

• Statutory capital and surplus of $3.5B1
• Potential for claims savings with the CareScout Services business and benefits from Live Well | Age Well program

Evaluating in-force management

actions for further downside protection